Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties, efficacy, safety and place in therapy

por Vavalà, Tiziana, Novello, Silvia
Publicado 2018

Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going?

por Passiglia, Francesco, Novello, Silvia
Publicado 2020

Should adjuvant treatment be offered to patients with stage IB non-small cell lung cancer?

por Passiglia, Francesco, Novello, Silvia
Publicado 2023

New emerging targets in cancer immunotherapy: the role of VISTA

por Tagliamento, Marco, Bironzo, Paolo, Novello, Silvia
Publicado 2020

Third line scenario in advanced non-small cell lung cancer: is the anti-angiogenetic strategy the only actor up to now?

por Mecca, Caterina, Bertaglia, Valentina, Novello, Silvia
Publicado 2019

Anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer

por Vavalà, Tiziana, Mariniello, Annapaola, Novello, Silvia
Publicado 2019

Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: are we actually ready?

por Tabbò, Fabrizio, Reale, Maria Lucia, Novello, Silvia
Publicado 2020

Fatigue in lung cancer patients: symptom burden and management of challenges

por Carnio, Simona, Di Stefano, Rosario Francesco, Novello, Silvia
Publicado 2016

Local for advanced, is this a paradox?

por Bungaro, Maristella, Paratore, Chiara, Bironzo, Paolo, Novello, Silvia
Publicado 2021

Management of Leptomeningeal Metastases in Non-oncogene Addicted Non-small Cell Lung Cancer

por Turkaj, Ana, Morelli, Anna M., Vavalà, Tiziana, Novello, Silvia
Publicado 2018

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?

por Passiglia, Francesco, Reale, Maria Lucia, Cetoretta, Valeria, Novello, Silvia
Publicado 2021

RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape

por Novello, Silvia, Califano, Raffaele, Reinmuth, Niels, Tamma, Antonella, Puri, Tarun
Publicado 2023

Improving lung cancer outcomes through smoking cessation: the Women Against Lung Cancer in Europe (WALCE) experience

por Capelletto, Enrica, Passiglia, Francesco, Ferraresi, Federica, Vallone, Stefania, Novello, Silvia
Publicado 2020

Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?—a literature review

por Leone, Gianmarco, Passiglia, Francesco, Bironzo, Paolo, Bertaglia, Valentina, Novello, Silvia
Publicado 2020

Exploring the immune-checkpoint inhibitors’ efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease

por Passiglia, Francesco, Cetoretta, Valeria, De Filippis, Marco, Napoli, Valerio, Novello, Silvia
Publicado 2021

Patients With Lung Cancer and Coronavirus Disease 2019 Epidemic: An Experience From an Italian University Hospital

por Scagliotti, Giorgio, Novello, Silvia, Veltri, Andrea, Boccuzzi, Adriana, Perboni, Alberto, Terzolo, Massimo
Publicado 2020

Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements

por Pisano, Chiara, De Filippis, Marco, Jacobs, Francesca, Novello, Silvia, Reale, Maria Lucia
Publicado 2022

Targeting KRAS in NSCLC: Old Failures and New Options for “Non-G12c” Patients

por Jacobs, Francesca, Cani, Massimiliano, Malapelle, Umberto, Novello, Silvia, Napoli, Valerio Maria, Bironzo, Paolo
Publicado 2021

Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes

por Mogavero, Andrea, Bironzo, Paolo, Righi, Luisella, Merlini, Alessandra, Benso, Federica, Novello, Silvia, Passiglia, Francesco
Publicado 2023

How Does Environmental and Occupational Exposure Contribute to Carcinogenesis in Genitourinary and Lung Cancers?

por Cani, Massimiliano, Turco, Fabio, Butticè, Simona, Vogl, Ursula Maria, Buttigliero, Consuelo, Novello, Silvia, Capelletto, Enrica
Publicado 2023